Lobbying client · LD-2 disclosures
Fabiani & Company on Behalf of Concert Pharmaceuticals
District of Columbia
13 filings from 2 registrants · 2010–2012 · latest filed Jan 20, 2013
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Budget/Appropriations
BUD
6 filings
Medical/Disease Research/Clinical Labs
MED
6 filings
Defense
DEF
3 filings
Who did the lobbying
Every lobbyist named on this client's filings.
- Danielle Organ Peters Danielle Organ Peters8 filingsthrough 2011
- Martin Green Martin GreenCovered position: Deputy Chief of Staff, Rep. Mark Souder4 filingsthrough 2010
Covered positions · 1 of 2 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: fabiani-company-on-behalf-of-concert-pharmaceuticals.